Component portfolio and prices
Portfolio
Portfolio of blood components and guidance
This provides details of therapeutic blood components supplied to hospitals, including constituents, and information on:
- specifications
- identification barcodes
- quality standards and monitoring
- storage and handling
- clinical indications and contraindications
- specialist requirements
- dosage, administration, recognition of adverse effects
- material safety data sheet
Prices
- National Commissioning Group's (NCG) consideration of our pricing and service proposals for 2021 - 22
- Blood component variable cost price list (PDF 198KB)
- Blood component full cost price list (PDF 198KB)
Availability of non stock and special components
- Availability of non stock and special components including components required for urgent requests
UK sourced FFP and cryoprecipitate components for neonates and infants
Since August 2020 these components have been manufactured to a revised specification to improve their quality for transfusion. This specification will be added to the component portfolio when it is next revised.